|
|
 |
DIBASIC CALCIUM PHOSPHATE DIHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ANHYDROUS TRISODIUM CITRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
WAKIX Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
GELATIN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|